[go: up one dir, main page]

HUE036876T2 - 4,5-Epoximorfinán származékot tartalmazó stabil tabletta - Google Patents

4,5-Epoximorfinán származékot tartalmazó stabil tabletta

Info

Publication number
HUE036876T2
HUE036876T2 HUE09822078A HUE09822078A HUE036876T2 HU E036876 T2 HUE036876 T2 HU E036876T2 HU E09822078 A HUE09822078 A HU E09822078A HU E09822078 A HUE09822078 A HU E09822078A HU E036876 T2 HUE036876 T2 HU E036876T2
Authority
HU
Hungary
Prior art keywords
tablet containing
stable tablet
epoxymorphinan derivative
epoxymorphinan
derivative
Prior art date
Application number
HUE09822078A
Other languages
English (en)
Inventor
Kotoe Ohta
Suguru Takaki
Yasuhide Horiuchi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of HUE036876T2 publication Critical patent/HUE036876T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE09822078A 2008-10-24 2009-10-23 4,5-Epoximorfinán származékot tartalmazó stabil tabletta HUE036876T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008274579 2008-10-24

Publications (1)

Publication Number Publication Date
HUE036876T2 true HUE036876T2 (hu) 2018-08-28

Family

ID=42119418

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE09822078A HUE036876T2 (hu) 2008-10-24 2009-10-23 4,5-Epoximorfinán származékot tartalmazó stabil tabletta

Country Status (16)

Country Link
US (1) US8829019B2 (hu)
EP (1) EP2356989B1 (hu)
JP (2) JP5648480B2 (hu)
KR (1) KR101682963B1 (hu)
CN (1) CN102196811B (hu)
AU (1) AU2009307367B2 (hu)
BR (1) BRPI0920599B1 (hu)
CA (1) CA2740476C (hu)
DK (1) DK2356989T3 (hu)
ES (1) ES2660001T3 (hu)
HU (1) HUE036876T2 (hu)
MX (1) MX2011004307A (hu)
PL (1) PL2356989T3 (hu)
PT (1) PT2356989T (hu)
TR (1) TR201802379T4 (hu)
WO (1) WO2010047381A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101960107B1 (ko) * 2010-10-19 2019-03-19 메모리얼 슬로안 케터링 캔서 센터 통증의 치료를 위한 ４,５에이-에폭시모르피난의 ６-아미도 유도체
DK2851075T3 (da) 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
TWI449704B (zh) * 2013-04-26 2014-08-21 Everlight Chem Ind Corp 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物
WO2016176657A1 (en) 2015-04-30 2016-11-03 Memorial Sloan-Kettering Cancer Center Mitragynine analogs and uses thereof
JP6858575B2 (ja) * 2016-01-29 2021-04-14 沢井製薬株式会社 ナルフラフィン含有口腔内崩壊錠
KR102427007B1 (ko) * 2016-07-29 2022-07-29 도레이 카부시키가이샤 광안정성이 향상된 고형 제제
KR102631066B1 (ko) 2017-03-31 2024-01-30 도레이 카부시키가이샤 날푸라핀을 함유하는 정제화된 의약 조성물
AU2019229892B2 (en) * 2018-03-08 2025-01-30 University Of Kansas Treatment of demyelinating diseases
US11214577B2 (en) 2019-03-29 2022-01-04 Humanwell Pharmaceutical US Morphinans useful for treating medical disorders
EP4334298A1 (en) 2021-06-14 2024-03-13 Scorpion Therapeutics, Inc. Urea derivatives which can be used to treat cancer
CN117398353A (zh) * 2023-12-04 2024-01-16 山东新时代药业有限公司 一种富马酸比索洛尔片剂

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2597475A (en) * 1949-03-09 1952-05-20 Gilbert & Barker Mfg Co Separator for removing water from gasoline
GB8820327D0 (en) 1988-08-26 1988-09-28 May & Baker Ltd New compositions of matter
CA2105072C (en) 1992-01-23 1998-07-28 Hiroshi Nagase Morphinan derivative and its pharmaceutical applications
ATE477793T1 (de) 1996-06-14 2010-09-15 Kyowa Hakko Kirin Co Ltd Eine im mund schnell zerfallende tablette
HU224964B1 (en) 1997-02-14 2006-04-28 Goedecke Ag Process for stabilization of naloxone and stable pharmaceutical compositions containing naloxone
WO1998043978A1 (fr) * 1997-03-27 1998-10-08 Toray Industries, Inc. Derives de morphinane et usage medical de ces derniers
DK0948965T3 (da) * 1997-07-11 2004-07-05 Toray Industries Stabile medicinske præparater indeholdende 4,5-epoxymorphinanderivater
US6572891B1 (en) * 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
JP4755353B2 (ja) 2001-04-02 2011-08-24 興和株式会社 ビタミンｂ１製剤
AU2003220290B2 (en) 2002-03-14 2007-06-14 Euro-Celtique S.A. Naltrexone hydrochloride compositions
BR0314754A (pt) * 2002-10-09 2005-07-26 Toray Industries Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
CN104383542B (zh) 2003-04-08 2017-09-26 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方
TW200507882A (en) * 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations
ATE451925T1 (de) 2004-10-06 2010-01-15 Eisai R&D Man Co Ltd Medizinische zusammensetzung, verfahren zu ihrer herstellung und verfahren zur stabilisierung einer dihydropyridin-verbindung in einer medizinischen zusammensetzung
JP4567640B2 (ja) 2005-07-29 2010-10-20 田辺三菱製薬株式会社 小型化塩酸サルポグレラート経口投与製剤
ES2464593T3 (es) * 2005-11-09 2014-06-03 Toray Industries, Inc. Agente terapéutico o profiláctico para trastornos funcionales digestivos
US8652529B2 (en) * 2005-11-10 2014-02-18 Flamel Technologies Anti-misuse microparticulate oral pharmaceutical form
JP5204976B2 (ja) 2006-01-27 2013-06-05 富山化学工業株式会社 イグラチモドを含有する速崩壊性錠剤
US20070196494A1 (en) 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
EA017832B1 (ru) * 2006-08-04 2013-03-29 Этифарм Гранулы и орально дезинтегрируемые таблетки, содержащие оксикодон
EP2609931B1 (en) * 2010-08-26 2020-09-16 Toray Industries, Inc. Immunogenic composition

Also Published As

Publication number Publication date
EP2356989A4 (en) 2013-05-08
PT2356989T (pt) 2018-03-09
JP2014141503A (ja) 2014-08-07
AU2009307367A1 (en) 2010-04-29
AU2009307367B2 (en) 2015-04-23
PL2356989T3 (pl) 2018-07-31
CN102196811B (zh) 2014-03-19
TR201802379T4 (tr) 2018-03-21
KR20110074613A (ko) 2011-06-30
DK2356989T3 (en) 2018-05-07
BRPI0920599A2 (pt) 2020-12-15
CA2740476C (en) 2016-04-05
JP5648480B2 (ja) 2015-01-07
US8829019B2 (en) 2014-09-09
EP2356989B1 (en) 2018-02-07
US20120114752A1 (en) 2012-05-10
WO2010047381A1 (ja) 2010-04-29
KR101682963B1 (ko) 2016-12-06
CN102196811A (zh) 2011-09-21
ES2660001T3 (es) 2018-03-20
BRPI0920599B1 (pt) 2021-10-19
JPWO2010047381A1 (ja) 2012-03-22
MX2011004307A (es) 2011-07-28
JP5971272B2 (ja) 2016-08-17
EP2356989A1 (en) 2011-08-17
CA2740476A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
PL2356989T3 (pl) Trwała tabletka zawierająca pochodną 4,5-epoksymorfinanu
IL201973A0 (en) 3,3-spiroindolinone derivatives
ZA201001797B (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
EP2361902A4 (en) 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
HRP20130728T1 (en) 7-piperidinoalkyl-3,4-dihydroquinolone derivative
IL225694A0 (en) Compounds 6,5- dihydro-h1-pyridine-2-one
SI2356123T1 (sl) Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
IL209423A0 (en) 4,5-dihydro-oxazol-2-yl derivatives
AP2010005345A0 (en) Indazole derivatives.
SI2513119T1 (sl) 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati
HUP0800591A2 (en) Stable pharmaceutical combination
EP2202231A4 (en) 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE
ZA201103374B (en) Shelf stable capsules
IL201444A0 (en) New 4, 8 - diphenyl - polyazanaphthalene derivatives
ZA201005346B (en) 3,8-diaminotetrahydroquinoline derivative
HK1162032A1 (en) 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2-
HK1161684A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds 56- -1h--2-
HK1151801A1 (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid
IL219623A0 (en) [1,5]-diazocin derivatives
HK1182939A1 (en) Stable pharmaceutical composition
EP2493476A4 (en) DEUTERATED 5,6-DIHYDRO-1H-PYRIDINE-2-ON COMPOUNDS
GB0813815D0 (en) Corcost Pre 1001,10
GB0808811D0 (en) Algabe 2.1
GB0816954D0 (en) Tablet holder